Literature DB >> 1979305

Ha-ras-1 alleles in Norwegian lung cancer patients.

D Ryberg1, T Tefre, S Ovrebø, V Skaug, L Stangeland, A Naalsund, R Baera, A L Børresen, A Haugen.   

Abstract

We have examined DNA restriction fragment length polymorphisms (RFLP) of the Ha-ras-1 gene in DNA from 118 lung cancer patients and 123 unaffected controls. When DNA samples were digested with MspI/HpaII restriction endonucleases. Southern blot analysis demonstrated 4 common, 4 intermediate and 7 different rare alleles in the combined population after hybridization to the pGDa1 probe. Six of the rare alleles were unique for the lung cancer group and 1 rare allele for the control group. The frequency of rare alleles in lung cancer patients (10/236) was significantly different (P less than 0.01) from the control group (1/246). The lung cancer group also had a significantly lower frequency of the common 2.57 kb fragment than the controls (P less than 0.02). The results thus indicate that Ha-ras genotyping may be of value in lung cancer risk assessment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979305     DOI: 10.1007/bf00205169

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  30 in total

1.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

2.  Allele frequency distribution of two highly polymorphic DNA sequences in three ethnic groups and its application to the determination of paternity.

Authors:  M Baird; I Balazs; A Giusti; L Miyazaki; L Nicholas; K Wexler; E Kanter; J Glassberg; F Allen; P Rubinstein
Journal:  Am J Hum Genet       Date:  1986-10       Impact factor: 11.025

3.  Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.

Authors:  H Sugimura; N E Caporaso; R V Modali; R N Hoover; J H Resau; B F Trump; J A Longergan; T G Krontiris; D L Mann; A Weston
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

4.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.

Authors:  A Weston; J C Willey; R Modali; H Sugimura; E M McDowell; J Resau; B Light; A Haugen; D L Mann; B F Trump
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Human population genetic studies of five hypervariable DNA loci.

Authors:  I Balazs; M Baird; M Clyne; E Meade
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

6.  Lack of correlation between rare Ha-ras alleles and urothelial cancer in Japan.

Authors:  J Ishikawa; S Maeda; R Takahashi; S Kamidono; T Sugiyama
Journal:  Int J Cancer       Date:  1987-10-15       Impact factor: 7.396

7.  Metabolic oxidation phenotypes as markers for susceptibility to lung cancer.

Authors:  R Ayesh; J R Idle; J C Ritchie; M J Crothers; M R Hetzel
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

8.  c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma.

Authors:  N K Hayward; R Keegan; D J Nancarrow; M H Little; P J Smith; R A Gardiner; G J Seymour; C Kidson; M F Lavin
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

9.  Personal and family history of respiratory disease and lung cancer risk.

Authors:  J M Samet; C G Humble; D R Pathak
Journal:  Am Rev Respir Dis       Date:  1986-09

Review 10.  Individual differences in cancer susceptibility.

Authors:  C C Harris; J J Mulvihill; S S Thorgeirsson; J D Minna
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

View more
  4 in total

1.  Population genetics of the HRAS1 minisatellite locus.

Authors:  B Devlin; T Krontiris; N Risch
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

2.  Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

Authors:  I Zborovskaya; A Gasparian; M Kitaeva; B Polotzky; N Tupitzin; Z Machaladze; S Gerasimov; M Shtutman; M Jakubovskaya; M Davidov; A Tatosyan
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

3.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

4.  Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.

Authors:  D Ryberg; T Tefre; V Skaug; L Stangeland; S Ovrebø; A Naalsund; A L Børresen; A Haugen
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.